Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huanghua Huarui Pharmaceutical is a prominent Chinese manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and chemical intermediates. The company is globally recognized as a leading producer of antimalarial medications, including chloroquine phosphate and hydroxychloroquine sulfate. Founded in 1992 and headquartered in Huanghua, Hebei Province, it operates advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards. Beyond antimalarials, the company provides raw materials for treatments targeting autoimmune diseases and other infectious conditions. Its products are distributed extensively within China and exported to numerous international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huanghua Huarui.